SCHEMBL12623935

SCHEMBL12623935

COCn1cnc2c(Cn3c4cc(F)c5ccoc5c4c4c5cccnc5oc(=O)c43)csc2c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12623788 0.83 — —
SCHEMBL12623914 0.81 DHPS (0.31) —
SCHEMBL12623091 0.78 MAPT (0.39) —
SCHEMBL12623662 0.78 — —
SCHEMBL12388862 0.77 — —
SCHEMBL12623743 0.77 HTR1A (0.31) —
SCHEMBL12623681 0.76 EGFR (0.34) —
SCHEMBL12623877 0.76 ACVR1 (0.33) —
SCHEMBL12623620 0.76 TNIK (0.32) —
SCHEMBL12623617 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110104109-A1 TETRACYCLIC INDOLE DERIVATIVES AND THEIR USE FOR TREATING OR PREVENTING VIRAL INFECTIONS MERCK SHARP & DOHME CORP. 2011-05-05 — — US disclosed
US-20110104109-A1 TETRACYCLIC INDOLE DERIVATIVES AND THEIR USE FOR TREATING OR PREVENTING VIRAL INFECTIONS MERCK SHARP & DOHME CORP. 2011-05-05 — — US disclosed
Send feedback